Crossmark

Knowledge and quality of life in cancer patients receiving immunotherapy for the first time. A cross-sectional study about being informed

Published Online: 2024-12-19

Published Print: 2025-01

Authors

Rivera, Josefina https://orcid.org/0009-0002-9629-8106
Montserrat-Moreno, Mireia

Arellano, Mónica

Brao, Isabel

Vilajosana, Esther

Sala, Rosa

López, Inmaculada

Fernández-Ortega, Paz https://orcid.org/0000-0001-7957-3909
License Information

Text and Data Mining valid from 2024-12-19

Version of Record valid from 2024-12-19
More Information

Article History

Received: 26 March 2024

Accepted: 6 December 2024

First Online: 19 December 2024

Declarations

:

: Approval was granted by the Institutional Review Board of ICO-IDIBELL (PR030/18). The study was performed in accordance with the ethical standards.

: Informed consent was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current